Considering the potential side effects of chronic CR and the difficulties with long-term adherence to such a dietary regimen in patients, the clinical application of established drugs capable of AMPK activation may provide a supplemental potential to treat patients after MI, in order to preserve LV function [42]. Here, PRKAA1 is linked to myocardial infarction.